Hjerteinfarkt i Norge i 2013

Tidsskrift for den Norske Laegeforening

Volumn 134, Issue 19, 2014, Pages 1841-1846

  Jortveit, Jarle ^a   Govatsmark, Ragna Elise Støre ^b   Digre, Tormod Aarlott ^b   Risøe, Cecilie ^c   Hole, Torstein ^d   Mannsverk, Jan ^e   Slørdahl, Stig Arild ^b,f   Halvorsen, Sigrun ^g  

^a Hjerteseksjonen   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Møre and Romsdal Hospital Trust   (Norway)

^e Hjertemedisinsk Avdeling   (Norway)

^f NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^g ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; DRUG UTILIZATION; FEMALE; FIBRINOLYTIC THERAPY; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HUMAN; MALE; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; NORWAY; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; REGISTER; RISK FACTOR; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG UTILIZATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NORWAY; PATIENT ADMISSION; PATIENT TRANSFER; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; QUALITY ASSURANCE, HEALTH CARE; REGISTRIES; RISK FACTORS; SEX FACTORS; THROMBOLYTIC THERAPY;

EID: 84908374000     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.14.0804     Document Type: Article

References (12)

1. Pasienter på somatiske sykehus, 2012. Oslo: Statistisk sentralbyrå, 2013. www.ssb.no/pasient/ (20.3.2014).
2. Dødsårsaker. 2012. Statistisk sentralbyrå. www.ssb.no/helse/statistikker/dodsarsak/aar (20.3.2014).
3. FOR 2011 - 12 - 16 nr 1250. Forskrift om innsamling og behandling av helseopplysninger i Nasjonalt register over hjerte- og karlidelser (Hjerte- og karregisterforskriften). www.lovdata.no/cgi-wift/ ldles?doc=/sf/sf/sf-20111216-1250.html#3-3 (20.3.2014).
4. LOV 2001-05-18 nr 24. Lov om helseregistre og behandling av helseopplysninger (helseregisterloven). www.lovdata.no/all/tl-20010518-024-002. html#8 (20.3.2014).
5. Brukermanual Norsk hjerteinfarktregister. http://www.helse-midt.no/no/HF/HEMIT/MRS/ Hjerteinfarktregister/Horisontal-meny-1/ Manualer/67571/ (20.3.2014).
6. Thygesen K, Alpert JS, Jaffe AS et al. Third universal definition of myocardial infarction. Eur Heart J 2012; 33: 2551 - 67.
7. Aakre KM, Rotevatn S, Hagve TA et al. Nye anbefalinger for tolking av troponinverdier. Tidsskr Nor Legeforen 2013; 133: 2241 - 2.
8. Hamm CW, Bassand JP, Agewall S et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999 - 3054.
9. Steg PG, James SK, Atar D et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569 - 619.
10. SwedeHeart. Årsrapport 2012. www.ucr.uu.se/swedeheart/index.php/arsrapporter (20.3.2014).
11. Helgeland JK, Kristoffersen DT, Hassani S et al. 30 dagers overlevelse etter innleggelse i norske sykehus i 2010 og 2011. www.kunnskapssenteret. no/publikasjoner/30-dagers-overlevelse-etterinnleggelse- i-norske-sykehus-i-2010-og-2011 (20.3.2014).
12. The EuroHOPE study group. Summary of the findings of the EuroHOPE project. 2014. www.eurohope.info/doc/summary.pdf (20.3.2014).